ALKEON CAPITAL MANAGEMENT LLC Q3 2022 Filing

Filed November 10, 2022

Portfolio Value

$30.9B

Holdings

120

Report Date

Q3 2022

Filing Type

13F-HR

All Holdings (120 positions)

#StockSharesValue% PortfolioType
101
BCRXBIOCRYST PHARMACEUTICALS INC
1,465,285$18.5M0.06%
102
PMVPPMV PHARMACEUTICALS INC
1,517,246$18.1M0.06%
103
RNG 0 03/01/25RINGCENTRAL INC
20,000,000$16.8M0.05%
104
COUP 0.375 06/15/26COUPA SOFTWARE INC
19,636,000$15.1M0.05%
105
CRBUCARIBOU BIOSCIENCES INC
1,222,091$12.9M0.04%
106
PCORPROCORE TECHNOLOGIES INC
226,929$11.2M0.04%
10711,100,000$10.7M0.03%
108
TGTXTG THERAPEUTICS INC
1,642,675$9.7M0.03%
10910,000,000$9.1M0.03%
110
AYX 0.5 08/01/24ALTERYX INC
10,000,000$8.9M0.03%
111
NDQINVESCO QQQ TR
31,030,000$8.3M0.03%Put
112
BJBJS WHSL CLUB HLDGS INC
110,000$8.0M0.03%
113
ALTREURALTAIR ENGR INC
173,212$7.7M0.02%
114
ORICORIC PHARMACEUTICALS INC
2,106,968$6.7M0.02%
115
DOCU 0 01/15/24DOCUSIGN INC
6,942,000$6.5M0.02%
116
SONYSONY GROUP CORPORATION
55,000$3.5M0.01%
1174,000,000$3.3M0.01%
118
ALTERYX INC
2,000,000$2.7M0.01%
119
ATVIEURACTIVISION BLIZZARD INC
25,495$1.9M0.01%
120
MREOMEREO BIOPHARMA GROUP PLC
2,135,600$1.8M0.01%
PreviousPage 2 of 2